Wedbush Securities Inc United Therapeutics Corp Transaction History

Wedbush Securities Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 20, 2020	SELL	$99.9 - $121.13 $230,769 - $279,810	-2,310 Closed	0 $0
Q1 2020 Apr 17, 2020	SELL	$79.39 - $115.35 $79,390 - $115,350	-1,000 Reduced 30.21%	2,310 $219,000
Q4 2019 Jan 16, 2020	SELL	$78.31 - $95.34 $54,817 - $66,738	-700 Reduced 17.46%	3,310 $292,000
Q3 2019 Oct 17, 2019	SELL	$74.85 - $85.99 $14,969 - $17,198	-200 Reduced 4.75%	4,010 $320,000
Q2 2019 Aug 01, 2019	BUY	$76.06 - $120.81 $53,242 - $84,567	700 Added 19.94%	4,210 $329,000
Q1 2019 Apr 17, 2019	SELL	$107.15 - $126.84 $21,430 - $25,368	-200 Reduced 5.39%	3,510 $412,000
Q3 2018 Nov 13, 2018	SELL	$113.81 - $129.46 $56,905 - $64,730	-500 Reduced 11.88%	3,710 $474,000
Q2 2018 Aug 03, 2018	BUY	$101.14 - $118.31 $50,570 - $59,155	500 Added 13.48%	4,210 $476,000
Q3 2017 Oct 31, 2017	BUY	$114.6 - $136.81 $425,166 - $507,565	3,710	3,710 $435,000

672

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.